Cardiotoxicity

Cancer treatment has improved extraordinarily in recent years. The development of targeted therapies has widened the cardiotoxic spectrum of antineoplastic drugs. Optimum management of cardiovascular disease before and during antineoplastic treatment is essential to reduce morbidity and mortality in...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of oncology 2010-10, Vol.21 (suppl-7), p.vii173-vii179
Hauptverfasser:	Brana, I., Tabernero, J.
Format:	Artikel
Sprache:	eng
Schlagworte:	adverse effects antineoplastic agents Antineoplastic Agents - adverse effects arrhythmia Arrhythmias, Cardiac - chemically induced Arrhythmias, Cardiac - drug therapy Arrhythmias, Cardiac - physiopathology Arrhythmias, Cardiac - prevention & control Cardiovascular Agents - therapeutic use chemically induced heart diseases Heart Diseases - chemically induced Heart Diseases - epidemiology Heart Diseases - prevention & control heart failure Humans Incidence Ischemia - chemically induced Ischemia - complications Ischemia - drug therapy Ischemia - prevention & control Molecular Targeted Therapy - methods Neoplasms - drug therapy Neoplasms - epidemiology QTc prolongation Ventricular Dysfunction, Left - chemically induced Ventricular Dysfunction, Left - drug therapy Ventricular Dysfunction, Left - prevention & control
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!